THC History Changed the Brain Metabolic Response to CB1 Blockade in Rats
A CB1 antagonist suppressed food-maintained responding more strongly in THC-tolerant rats than in drug-naive rats. A glucose-utilization mapping method also showed more extensive metabolic changes after the tolerant exposure history.
Behavior was paired with metabolic mapping
Rats learned to press a lever for food pellets. After antagonist administration and behavioral testing, researchers used quantitative radiolabeled deoxyglucose autoradiography to examine cerebral glucose utilization. This is a tissue-based metabolic method, not a THC assay or a direct measure of subjective hunger.
The response extended beyond the initial pattern
In the initial experiment, antagonist-related reductions in responding accompanied decreases in glucose utilization concentrated in limbic areas involved in motivated behavior. In tolerant animals, responding was more strongly suppressed and metabolic decreases were more intense and widespread, including hypothalamic regions relevant to ingestive behavior.
Lower responding has several interpretive limits
A food-reinforced response rate is an observable task outcome. It does not by itself identify a particular internal experience or prove a specific withdrawal symptom. Likewise, reduced regional glucose utilization should not be described as permanent brain injury. The measurements characterize an acute response to receptor blockade after a defined exposure history.
The findings demonstrate that the same antagonist can have different functional consequences depending on prior cannabinoid treatment. They support attention to exposure history in mechanistic interpretation, while stopping short of identifying how a particular cannabis user would respond or whether everyday appetite would change in the same way.
Related: interpreting cannabis tolerance claims.
Research cited
Freedland CS; Whitlow CT; Smith HR; Porrino LJ. Functional consequences of the acute administration of the cannabinoid receptor antagonist, SR141716A, in cannabinoid-naive and -tolerant animals: a quantitative 2-[14C]deoxyglucose study. Brain research (2003). doi:10.1016/s0006-8993(02)03999-9. Findings discussed from the study abstract.
